Clinical Trial Update: Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of a 4-month daily regimen (2HZPM/2HPM) for pulmonary tuberculosis; the study is currently active but …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• 2HZPM/2HPM regimen

Snippet

Sponsor: Kaohsiung Veterans General Hospital. | Conditions: Tuberculosis, Pulmonary | Phase 3 | Status: ACTIVE_NOT_RECRUITING